KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $33.0 million.

  • Cme Group's Gains from Investment Securities rose 86.55% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.5 million, marking a year-over-year increase of 104.14%. This contributed to the annual value of $33.0 million for FY2024, which is 195.93% up from last year.
  • Per Cme Group's latest filing, its Gains from Investment Securities stood at $33.0 million for FY2024, which was up 195.93% from -$34.4 million recorded in FY2023.
  • Cme Group's Gains from Investment Securities' 5-year high stood at $41.4 million during FY2020, with a 5-year trough of -$41.3 million in FY2022.
  • Over the past 3 years, Cme Group's median Gains from Investment Securities value was -$34.4 million (recorded in 2023), while the average stood at -$14.2 million.
  • In the last 5 years, Cme Group's Gains from Investment Securities plummeted by 230.28% in 2022 and then skyrocketed by 195.93% in 2024.
  • Over the past 5 years, Cme Group's Gains from Investment Securities (Yearly) stood at $41.4 million in 2020, then dropped by 23.43% to $31.7 million in 2021, then tumbled by 230.28% to -$41.3 million in 2022, then grew by 16.71% to -$34.4 million in 2023, then soared by 195.93% to $33.0 million in 2024.